Releasing the neuronal brake: Inhibiting AhR to enhance axon regeneration

Clinical and Translational Medicine · Published 2026-07-01 · DOI 10.1002/ctm2.70733

Free full text

Authors (2)

Daniel Halperin, Hongyan Zou

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Citation

Halperin, D., Zou, H. (2026). Releasing the neuronal brake: Inhibiting AhR to enhance axon regeneration. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70733

Related articles

• Engineered exosomes improve myocardial cell membrane integrity and heart function in dystrophic cardiomyopathy · Clinical and Translational Medicine · 2026 · Same journal
• Remodelling the tumour microenvironment and beyond: ERO1A as a multifaceted regulator and emerging therapeutic target in cancer · Clinical and Translational Medicine · 2026 · Same journal
• Role of LncSNHG5 in MAFLD: Mechanisms of Arid1a K391 lactylation and lipid accumulation · Clinical and Translational Medicine · 2026 · Same journal
• Sintilimab plus cisplatin and nab‐paclitaxel induction treatment for locally advanced borderline‐resectable oesophageal squamous cell carcinoma: A single‐arm, prospective, phase 2 study (NEOCRTEC2001) · Clinical and Translational Medicine · 2026 · Same journal
• Integrating pathological morphologies and molecular profiles for clinical biomarker discovery with unified multimodal embedding · Clinical and Translational Medicine · 2026 · Same journal
• Artificial intelligence and oral microbiome: Reshaping the diagnostic and therapeutic paradigm of OSCC · Clinical and Translational Medicine · 2026 · Same journal
• Investigations into the aetiopathogenesis of orofacial granulomatosis using multiple omics technologies reveal a potential role for B cells · Clinical and Translational Medicine · 2026 · Same journal
• The emerging dialogue between synthetic genomics and clinical research · Clinical and Translational Medicine · 2026 · Same journal
• Ubc9‐mediated SUMOylation of Ninj1 alleviates inflammatory responses in hepatic ischaemia/reperfusion injury · Clinical and Translational Medicine · 2026 · Same journal
• Proteomic profiling reveals ACTN1‐mediated cytoskeletal remodelling and hyperplasia of cerebrovascular smooth muscle cells in moyamoya disease · Clinical and Translational Medicine · 2026 · Same journal